Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report

Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report

Direct oral anticoagulants (DOAC) are the preferred choice of anticoagulation for patients with atrial fibrillation. DOACs are always preferred over vitamin K antagonists due to their better safety profile in terms of life-threatening bleeding and decreased need for INR (international normalised rat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cureus 2024, Vol.16 (1), p.e52332-e52332
Hauptverfasser: Chakraborty, Shudipan, Salman, Fnu, Baghal, Moaaz, Tahir, Ayesha, Baqi, Abdul, Singh, Hemindermeet, Taleb, Mohammed
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e52332
container_issue 1
container_start_page e52332
container_title Cureus
container_volume 16
creator Chakraborty, Shudipan
Salman, Fnu
Baghal, Moaaz
Tahir, Ayesha
Baqi, Abdul
Singh, Hemindermeet
Taleb, Mohammed
description Direct oral anticoagulants (DOAC) are the preferred choice of anticoagulation for patients with atrial fibrillation. DOACs are always preferred over vitamin K antagonists due to their better safety profile in terms of life-threatening bleeding and decreased need for INR (international normalised ratio) monitoring. Although the most commonly used anticoagulation, failure to DOAC has been reported. Here we present a rare case of rivaroxaban failure presenting with left renal infarction in a patient who had dense spontaneous echocardiographic contrast in the left atrium visualised by transthoracic echocardiography.
doi_str_mv 10.7759/cureus.52332
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928242149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2928242149</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_29282421493</originalsourceid><addsrcrecordid>eNqVjEFPAjEQhRsjCUS5-QPm6AVsuwu7640QN3rbEBOOZNgMMqS22Okaf74levDq6b2XfN9T6s7oeVUtmod-iDTIfGGLwl6piTXLelaburz-08dqKnLSWhtdWV3piUob_sQYvnCPHlpkl1-giyTkE_s32HI6woY8OnjxB4x94uCBPSB0mDhTP0hHUVjSZa9S5Iy3vI_sHF6ER1jBGoXy0znEdKtGB3RC09-8Ufft0-v6eXaO4WMgSbt3lp6y7CkMsrONrW1pTdkU_0C_Ab-SVx8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2928242149</pqid></control><display><type>report</type><title>Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Chakraborty, Shudipan ; Salman, Fnu ; Baghal, Moaaz ; Tahir, Ayesha ; Baqi, Abdul ; Singh, Hemindermeet ; Taleb, Mohammed</creator><creatorcontrib>Chakraborty, Shudipan ; Salman, Fnu ; Baghal, Moaaz ; Tahir, Ayesha ; Baqi, Abdul ; Singh, Hemindermeet ; Taleb, Mohammed</creatorcontrib><description>Direct oral anticoagulants (DOAC) are the preferred choice of anticoagulation for patients with atrial fibrillation. DOACs are always preferred over vitamin K antagonists due to their better safety profile in terms of life-threatening bleeding and decreased need for INR (international normalised ratio) monitoring. Although the most commonly used anticoagulation, failure to DOAC has been reported. Here we present a rare case of rivaroxaban failure presenting with left renal infarction in a patient who had dense spontaneous echocardiographic contrast in the left atrium visualised by transthoracic echocardiography.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.52332</identifier><language>eng</language><ispartof>Cureus, 2024, Vol.16 (1), p.e52332-e52332</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>781,785,4491,27930</link.rule.ids></links><search><creatorcontrib>Chakraborty, Shudipan</creatorcontrib><creatorcontrib>Salman, Fnu</creatorcontrib><creatorcontrib>Baghal, Moaaz</creatorcontrib><creatorcontrib>Tahir, Ayesha</creatorcontrib><creatorcontrib>Baqi, Abdul</creatorcontrib><creatorcontrib>Singh, Hemindermeet</creatorcontrib><creatorcontrib>Taleb, Mohammed</creatorcontrib><title>Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report</title><title>Cureus</title><description>Direct oral anticoagulants (DOAC) are the preferred choice of anticoagulation for patients with atrial fibrillation. DOACs are always preferred over vitamin K antagonists due to their better safety profile in terms of life-threatening bleeding and decreased need for INR (international normalised ratio) monitoring. Although the most commonly used anticoagulation, failure to DOAC has been reported. Here we present a rare case of rivaroxaban failure presenting with left renal infarction in a patient who had dense spontaneous echocardiographic contrast in the left atrium visualised by transthoracic echocardiography.</description><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2024</creationdate><recordtype>report</recordtype><recordid>eNqVjEFPAjEQhRsjCUS5-QPm6AVsuwu7640QN3rbEBOOZNgMMqS22Okaf74levDq6b2XfN9T6s7oeVUtmod-iDTIfGGLwl6piTXLelaburz-08dqKnLSWhtdWV3piUob_sQYvnCPHlpkl1-giyTkE_s32HI6woY8OnjxB4x94uCBPSB0mDhTP0hHUVjSZa9S5Iy3vI_sHF6ER1jBGoXy0znEdKtGB3RC09-8Ufft0-v6eXaO4WMgSbt3lp6y7CkMsrONrW1pTdkU_0C_Ab-SVx8</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Chakraborty, Shudipan</creator><creator>Salman, Fnu</creator><creator>Baghal, Moaaz</creator><creator>Tahir, Ayesha</creator><creator>Baqi, Abdul</creator><creator>Singh, Hemindermeet</creator><creator>Taleb, Mohammed</creator><scope>7X8</scope></search><sort><creationdate>20240101</creationdate><title>Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report</title><author>Chakraborty, Shudipan ; Salman, Fnu ; Baghal, Moaaz ; Tahir, Ayesha ; Baqi, Abdul ; Singh, Hemindermeet ; Taleb, Mohammed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_29282421493</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Chakraborty, Shudipan</creatorcontrib><creatorcontrib>Salman, Fnu</creatorcontrib><creatorcontrib>Baghal, Moaaz</creatorcontrib><creatorcontrib>Tahir, Ayesha</creatorcontrib><creatorcontrib>Baqi, Abdul</creatorcontrib><creatorcontrib>Singh, Hemindermeet</creatorcontrib><creatorcontrib>Taleb, Mohammed</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chakraborty, Shudipan</au><au>Salman, Fnu</au><au>Baghal, Moaaz</au><au>Tahir, Ayesha</au><au>Baqi, Abdul</au><au>Singh, Hemindermeet</au><au>Taleb, Mohammed</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report</atitle><jtitle>Cureus</jtitle><date>2024-01-01</date><risdate>2024</risdate><volume>16</volume><issue>1</issue><spage>e52332</spage><epage>e52332</epage><pages>e52332-e52332</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Direct oral anticoagulants (DOAC) are the preferred choice of anticoagulation for patients with atrial fibrillation. DOACs are always preferred over vitamin K antagonists due to their better safety profile in terms of life-threatening bleeding and decreased need for INR (international normalised ratio) monitoring. Although the most commonly used anticoagulation, failure to DOAC has been reported. Here we present a rare case of rivaroxaban failure presenting with left renal infarction in a patient who had dense spontaneous echocardiographic contrast in the left atrium visualised by transthoracic echocardiography.</abstract><doi>10.7759/cureus.52332</doi></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Cureus, 2024, Vol.16 (1), p.e52332-e52332
issn 2168-8184
2168-8184
language eng
recordid cdi_proquest_miscellaneous_2928242149
source PubMed Central Open Access; PubMed Central
title Rivaroxaban Failure Presenting With Renal Infarction in a Patient With Persistent Atrial Fibrillation: A Case Report
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T10%3A58%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Rivaroxaban%20Failure%20Presenting%20With%20Renal%20Infarction%20in%20a%20Patient%20With%20Persistent%20Atrial%20Fibrillation:%20A%20Case%20Report&rft.jtitle=Cureus&rft.au=Chakraborty,%20Shudipan&rft.date=2024-01-01&rft.volume=16&rft.issue=1&rft.spage=e52332&rft.epage=e52332&rft.pages=e52332-e52332&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.52332&rft_dat=%3Cproquest%3E2928242149%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928242149&rft_id=info:pmid/&rfr_iscdi=true